Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Interest & Investment Income (2019 - 2025)

Historic Interest & Investment Income for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Q3 2025 value amounting to $10.3 million.

  • Madrigal Pharmaceuticals' Interest & Investment Income fell 2082.34% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.0 million, marking a year-over-year decrease of 1245.06%. This contributed to the annual value of $46.7 million for FY2024, which is 13829.81% up from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Interest & Investment Income of $10.3 million as of Q3 2025, which was down 2082.34% from $8.2 million recorded in Q2 2025.
  • Over the past 5 years, Madrigal Pharmaceuticals' Interest & Investment Income peaked at $14.2 million during Q2 2024, and registered a low of $52000.0 during Q4 2021.
  • In the last 5 years, Madrigal Pharmaceuticals' Interest & Investment Income had a median value of $3.6 million in 2023 and averaged $5.1 million.
  • In the last 5 years, Madrigal Pharmaceuticals' Interest & Investment Income tumbled by 9270.96% in 2021 and then soared by 537246.38% in 2023.
  • Quarter analysis of 5 years shows Madrigal Pharmaceuticals' Interest & Investment Income stood at $52000.0 in 2021, then soared by 1969.23% to $1.1 million in 2022, then skyrocketed by 732.06% to $9.0 million in 2023, then grew by 23.75% to $11.1 million in 2024, then decreased by 6.96% to $10.3 million in 2025.
  • Its Interest & Investment Income stands at $10.3 million for Q3 2025, versus $8.2 million for Q2 2025 and $9.4 million for Q1 2025.